Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles matching "pancreatic diseases"

ResearchPUBMEDToday

CACRC-Pan: A Concept Annotated Case Report Corpus and Processing Pipeline for Rare Pancreatic Diseases.

Researchers created a new computer tool that helps doctors identify rare pancreatic diseases by reading medical case reports. The tool learns to recognize symptoms described in patient stories and then suggests which disease a patient might have. Six rare pancreatic diseases are included: autoimmune pancreatitis (types 1 and 2), cystic fibrosis, hereditary chronic pancreatitis, pancreatic sufficiency, and Shwachman-Diamond syndrome.

WHY IT MATTERSThis tool could help doctors diagnose rare pancreatic diseases faster and more accurately by automatically identifying key symptoms in patient records, potentially reducing the years of diagnostic delay that patients with these conditions typically experience.
Good to knowAutoimmune pancreatitis type 1Autoimmune pancreatitis type 2Cystic fibrosis
PipelineRSSMay 1

FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug

The FDA has given approval for Revolution Medicines to offer an experimental pancreatic cancer drug called daraxonrasib to patients outside of clinical trials through a special program called expanded access. This program allows patients with serious illnesses who have no other treatment options to try investigational drugs before they are fully approved. This is an important step forward for patients with pancreatic cancer who may benefit from this new treatment.

WHY IT MATTERSPatients with advanced pancreatic cancer who have exhausted standard treatment options may now have access to daraxonrasib through expanded access, potentially offering a new therapeutic option while the drug completes its clinical development.
💬 Ask your doctorpancreatic cancer

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases